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Abstract 
Background: Appropriate treatment of life-threatening Plasmodium falciparum malaria requires in-patient care. 
Although the proportion of severe cases accessing in-patient care in endemic settings strongly affects overall case 
fatality rates and thus disease burden, this proportion is generally unknown. At present, estimates of malaria mortality 
are driven by prevalence or overall clinical incidence data, ignoring differences in case fatality resulting from varia-
tions in access. Consequently, the overall impact of preventive interventions on disease burden have not been validly 
compared with those of improvements in access to case management or its quality.
Methods: Using a simulation-based approach, severe malaria admission rates and the subsequent severe malaria 
disease and mortality rates for 41 malaria endemic countries of sub-Saharan Africa were estimated. Country differ-
ences in transmission and health care settings were captured by use of high spatial resolution data on demographics 
and falciparum malaria prevalence, as well as national level estimates of effective coverage of treatment for uncom-
plicated malaria. Reported and modelled estimates of cases, admissions and malaria deaths from the World Malaria 
Report, along with predicted burden from simulations, were combined to provide revised estimates of access to 
in-patient care and case fatality rates.
Results: There is substantial variation between countries’ in-patient admission rates and estimated levels of case 
fatality rates. It was found that for many African countries, most patients admitted for in-patient treatment would not 
meet strict criteria for severe disease and that for some countries only a small proportion of the total severe cases are 
admitted. Estimates are highly sensitive to the assumed community case fatality rates. Re-estimation of national level 
malaria mortality rates suggests that there is substantial burden attributable to inefficient in-patient access and treat-
ment of severe disease.
Conclusions: The model-based methods proposed here offer a standardized approach to estimate the numbers of 
severe malaria cases and deaths based on national level reporting, allowing for coverage of both curative and preven-
tive interventions. This makes possible direct comparisons of the potential benefits of scaling-up either category of 
interventions. The profound uncertainties around these estimates highlight the need for better data.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Each year the prompt and effective treatment of Plasmo-
dium falciparum malaria saves the lives of children across 
malaria endemic countries. Recent analysis has estimated 
that scale-up of vector control (insecticide-treated nets 
and indoor residual spraying) and artemisinin combina-
tion therapy have reduced malaria prevalence by 50% 
and clinical incidence by 40% in endemic Africa over the 
years 2000–2015 [1]. However, it is unclear how many 
deaths are prevented each year by the treatment of both 
uncomplicated and severe clinical malaria. Hospital case 
fatality rates for well-defined severe malaria are relatively 
well established [2, 3]. However these do not translate 
directly into estimates of the impact of effective man-
agement of severe disease on malaria mortality rates, for 
which only estimates based on expert opinion are avail-
able [4] and, to date, there are no good estimates of how 
these translate into numbers of malaria deaths averted.
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The World Health Organization’s annual World 
Malaria Report (WMR) [5] provides information on 
country-specific numbers of cases and admissions 
reported by National Health Ministries. The admission 
rates vary enormously, raising the question of whether 
they can be interpreted in the same way for all coun-
tries. These statistics make no distinction between differ-
ent levels of disease severity, and it would appear that in 
many countries large numbers of uncomplicated malaria 
patients are admitted as in-patients to health facilities.
The inclusion of uncomplicated malaria patients in sta-
tistics on malaria admission means that these numbers 
cannot be used uncritically to estimate the proportion of 
severely ill people that access such care. In general, pop-
ulation-based estimates must be used to estimate access 
rates, and recent Demographic and Health Surveys 
(DHS) and Malaria Indicator Surveys (MIS), have made 
much more data available on access to care for malaria 
[6–8]. These data demonstrate enormous variations 
between countries in access to treatment for uncompli-
cated malaria [9], but such surveys do not provide good 
estimates of severe malaria incidence in the community 
because it is a relatively infrequent acute disease, unlikely 
to be encountered at the exact time of a household visit, 
and cannot be reliably diagnosed from reported signs 
and symptoms. There are consequently no good direct 
estimates of the numbers of severe episodes in endemic 
countries that fail to access appropriate care. Several 
studies have found no better source of information on 
this than the 1996 review of McCombie [10], which is 
methodologically limited and now very outdated. Good-
man et al. [11] summarized those results in 2000, propos-
ing that on average 48% (with high and low estimates of 
19 and 88%) of severe malaria cases in the sub-Saharan 
region are admitted, and several models have continued 
to use this value (or similar constant values [12, 13]) in 
the absence of any more reliable source [14, 15].
There are thus gaps in routine statistics on overall inci-
dence of severe disease, on the corresponding care-gap, 
and its public health consequences. To contribute to fill-
ing these gaps this study proposes model-based methods 
to estimate the number of severe malaria cases occur-
ring in each malaria endemic country in sub-Saharan 
Africa, the proportion admitted to in-patient care, and 
the corresponding public health burden. These methods 
rely on available national or geographic reported clinical 
and treatment data, as well as available risk and expo-
sure information for each country. Specifically, the esti-
mates are based on the following data or model inputs: 
(1) estimates of the distributions of transmission inten-
sities based on the prevalence data assembled by the 
Malaria Atlas Project (MAP) [16]; (2) the effective cov-
erage of treatment for uncomplicated malaria, estimated 
from survey data [9]; (3) national level reports of num-
bers of in-patient deaths and estimates of total deaths 
from WMR [5]; (4) models for severe disease incidence as 
allowing for the effects of treating uncomplicated disease, 
and calibrated by triangulating the relationships between 
severe disease, mortality, and transmission intensity [14]. 
By applying published estimates of case fatality rates 
among both in-patients and in the community we esti-
mate the numbers of clinical episodes and deaths averted 
by case management of both uncomplicated and severe 
malaria and use these estimates to project the current 
burden of malaria in Africa. These estimates additionally 
indicate the public health impact that could be achieved 
by improving access to appropriate care for severe 
disease.
Methods
Data sources and notation
For each of the 41 countries in sub-Saharan Africa for 
which sufficient data was available, estimates for 2014 
of the average incidence rate of both uncomplicated (U) 
and severe (S) clinical malaria, and the malaria specific 
(direct) mortality rate (D), were collated. In each case the 
estimates were disaggregated according to whether the 
event was as an in-patient (subscript h) or in the com-
munity (subscript c) or both combined (subscript t). 
The estimates were obtained from two sources, either 
as reported in WMR, denoted by accent ̂, or calcu-
lated from simulation models of malaria epidemiology, 
denoted by accent ¯. Notation and variables are described 
in Table 1.
WMR of 2015 [5] provides values for the 2014 overall 
incidence rate of clinical malaria in each country, Cˆt, of 
the number of cases that are admitted, Cˆh, of the over-
all mortality rates Dˆt, and the rate of in-patients malaria 
death, Dˆh.
The WMR is an important source of information on 
national trends in malaria incidence and mortality, but 
is reliant on hospital and national reporting. An impor-
tant objective of this work is to support improvements in 
the accuracy and utility of these statistics. There is large 
uncertainty in the estimates resulting from country dif-
ferences in reporting methodology, inconsistent case 
definitions and potentially biased or flawed reporting. 
These are, however, the best available data. The present 
study proposes a practical methodology to incorpo-
rate admission rates for severe malaria into estimates of 
malaria mortality using the WMR data, and the results 
should be regarded with caution given the uncertain-
ties surrounding WMR estimates. Low reported admis-
sion rates in the WMR may reflect poor access to care or 
incomplete reporting, or both. Unexpectedly high admis-
sion rates, on the other hand, could be a consequence of 
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laxer definitions of severe malaria. A direct measure of 
reporting biases, even if thought to be considerable, has 
not been be undertaken in this work due to the lack of 
alternative data.
Each year the WMR generally reports health facil-
ity data and estimates of incidence and mortality for all 
sub-Saharan African countries. Only 41 countries were 
included in the present study due to missing data in the 
WMR for some countries (Equatorial Guinea, South 
Sudan, Cabo Verde and Swaziland) or missing parasite 
prevalence distributions from the MAP (South Africa).
Alternative estimates to those in WMR, and also esti-
mates of other parameters not available from WMR are 
derived using the OpenMalaria microsimulation mod-
els [13]. The OpenMalaria platform supports an ensem-
ble of stochastic, individual-based, simulation models of 
malaria in humans [13, 17, 18] that can be used for cali-
brating different malariological indices against each other 
[19]. This includes sub-models of infection of humans 
[20], incidence of morbidity including severe and in-
patient cases and mortality [14].
To capture effects of the different malaria transmission 
settings and health care systems for each country, these 
models were linked to population surfaces from World-
Pop [21], national level estimates of effective coverage of 
treatment for uncomplicated malaria [9] (E14, based on 
survey data with 14-day recall periods) and high spatial 
resolution posterior distributions of the P. falciparum 
prevalence for 2–10  year olds (PfPR2–10) for 2014 from 
the Malaria Atlas Project (MAP)   [16]. Distributions of 
entomological inoculation rates (EIR) were estimated 
using these PfPR2–10 distributions, as described previ-
ously [22]. Simulations were performed using six of the 
OpenMalaria ensemble models (capturing heterogeneity 
in immunity decay, transmission and co-morbidities) for 
each country using these country-specific inputs of EIR, 
population demographics, and effective treatment for 
uncomplicated clinical disease, as described previously 
[22], and detailed in the Additional file  1. The value for 
the proportion of severe cases that are admitted for in-
patient care was assumed to be as previously estimated 
(µ = µ0 = 0.48) [14], which also results in untreated or 
out-patient severe cases to have approximately twice the 
risk of dying as do severe malaria cases that are admitted 
(odds ratio: ϕ¯1 = 2.1 [14]). Simulation outputs included 
yearly incidence of total uncomplicated (U¯t) and severe 
(S¯t) malaria clinical cases, as well as malaria deaths 
(D¯t,µ0,ϕ1. All model-based deaths in this work are deaths 
directly attributable to malaria, and indirect deaths [14] 
associated with co-morbidities also estimated by Open-
Malaria are not considered.
Case fatality rates
The public health consequences of severe malaria depend 
on the proportion of cases that die. This proportion, 
referred to as the case fatality rate (CFR), depends on 
whether the patient receives in-patient care.
The proportion of malaria in-patients who die (the 
CFR, Qˆh) estimated from WMR data is dependent on 
reported incidence of in-patient deaths (Dˆh) and in-
patients, Cˆh, namely:
An independent, and age-dependent, estimate of the 
hospital CFR is provided by Reyburn et al. [23] for Tan-
zania. This function, (with age-weighted average Qh), is 
an input used in calibration of OpenMalaria models, as 
previously detailed [14]. In OpenMalaria, only severe 
malaria cases are simulated as being admitted, thus the 
hospital CFR (Qh) in OpenMalaria is:
(1)Qˆh =
Dˆh
Cˆh
Table 1 Variables and parameter descriptions
a The mortality rates from WMR are compared to the direct mortality from 
OpenMalaria, the additional indirect mortality due to co-morbidities is not 
considered
Name Description
Variables
U Incidence rate of uncomplicated clinical malaria (per 100,000 
person per year)
S Incidence rate of severe clinical malaria (per 100,000 person per 
year)
C Incidence rate of total clinical malaria (C = U + S)
(per 100,000 person per year)
D Incidence rate of malaria mortalitya (per 100,000 person per year)
μ Proportion of severe cases treated as in-patients (−)
r Ratio of severe to total clinical cases for in-patients (−)
Q
R
Case fatality rate (−)
Estimated public health impact (as malaria mortality) averted 
with maximal improvement to admittance of severe disease 
patient (μ = 1) (per 100,000 person per year)
ρ The overall ratio of the number of deaths per year in WMR
(Dˆt) [allowing for the national population (N)],
to that predicted by OpenMalaria (D¯t ,µ,ϕ¯1)
Subscripts
h Indicates in-patient event
c Indicates event in community
t Indicates total events
PB Indicates prediction-biased estimate
DA Indicates deaths-adjusted estimate
µ0 Indicates estimate used in OpenMalaria analysis for the propor-
tion of severe cases treated as in-patients (usually µ0 = 0.48)
ϕx Indicates estimate calculated with the odds ratio of value ϕx
Accents
¯ Indicates estimation from OpenMalaria simulations
ˆ Indicates estimation from WMR
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In OpenMalaria parameterizations that assume the 
proportion of severe cases admitted is µ0 = 0.48, then 
the odds ratio of dying in the community compared to in-
patient was estimated to be double (ϕ1 = 2.1 [14]) lead-
ing to a CFR for severe disease in the community of:
Fraction and number of in‑patients with severe disease
The fraction of admissions that have severe disease is a 
potentially important indicator of the appropriateness 
of admission criteria, but cannot be directly estimated 
from WMR because admissions are not differentiated 
into severe cases and uncomplicated ones. Hence, direct 
estimates of country-specific incidence of severe disease 
among in-patients (Sˆh) are not available from WMR, 
however, it is possible to calculate Sˆh using estimated case 
fatality rates.
The in-patient case fatality rate from OpenMalaria, Q¯h , 
can be applied also to the severe cases in WMR so that:
and hence, the implicit number of severe cases among 
the admissions reported in WMR, Sˆh, is obtained as:
Let r be the ratio of severe to total cases in a given set-
ting, i.e., the fraction of in-patients that are severe is:
In OpenMalaria, the admission of uncomplicated 
cases as in-patients is assumed to be irrelevant, thus 
Uh = 0⇒ rh = 1. However, since this assumption does 
not hold for WMR data, that is Uˆh for some countries is 
non-negligible, in general rˆh < 1, and the best-estimate of 
the proportion of in-patient cases that are severe is:
Substituting for WMR reported number of severe 
cases admitted (Eq. 5) results in an estimated fraction of 
in-patients with severe disease, as the ratio of in-patient 
(2)
Qh =
Dh
Sh
(3)Qc,ϕ1 =
ϕ1Qh
1+ϕ1Qh−Qh
(4)
Dh
Sh
=
Dˆh
Sˆh
= Qh
(5)Sˆh =
Dˆh
Qh
(6)rh =
Sh
Ch
=
Sh
Sh +Uh
(7)rˆh =
Sˆh
Sˆh + Uˆh
CFRs from WMR and from the OpenMalaria predic-
tions, namely:
Estimates of the total incidence of severe disease and the 
proportion admitted
The total incidence of severe disease, St, is an important 
measure of burden but has not previously been estimated 
in national statistics and is not directly available from 
WMR because admissions are not classified by severity 
and the number of severe cases in the community is not 
available. To estimate the total incidence of severe dis-
ease and the proportion that are admitted we took two 
approaches that combine reported national level malaria 
incidence from WMR and model estimates:
1. Approach 1: OpenMalaria generally simulates higher 
mortality rates than those in WMR. The OpenMalaria 
estimate of the overall incidence of severe malaria, St , 
might be higher than contemporary rates because it is 
parameterized using data from historical studies when 
co-infections, which contribute to the pathogenesis of 
severe disease, were more frequent than they are now 
[14].
The overall ratio, ρ, of the number of deaths per year in 
WMR (Dˆt) [allowing for the national population (N)], to 
that predicted by OpenMalaria (Dt,µ,ϕ1) is:
where the summations are over all 41 countries, and the 
value of µ for each country is determined via an iterative 
algorithm as described in the Additional file 1. This ratio 
can be used for scaling the incidence of model estimates 
of severe disease to WMR, in principle allowing for the 
decrease in comorbidity over time:
This adjusted estimates of severe disease incidence pro-
vides the prediction-biased estimate, µPB, of the fraction 
of all severe cases that are admitted, namely:
2. Approach 2: A second set of estimates was derived by 
using the reported or inferred number of WMR deaths 
and assuming the applicability of the community case 
fatality rate from OpenMalaria, Qc. These are the deaths-
adjusted estimate of total severe malaria (St) obtained by 
(8)rˆh =
Qˆh
Qh
(9)ρµ,ϕ1 =
∑
NDˆt∑
NDt,µ,ϕ1
(10)SPB = ρSt
(11)µPB =
Sˆh
SPB
=
Dˆh
QhρSt
=
rˆhCˆh
ρSt
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expanding St as the sum of Sh) and Sc; the former is by 
definition equal to  rhCh and the latter follows from the 
fact that cases can be computed as the ratio of deaths and 
the case fatality rate:
and the deaths-adjusted estimate, µDA, of the fraction 
admitted to in-patient care is:
Mortality estimates adjusting for access to in‑patient care
The overall incidence of malaria deaths Dt, depends on 
the proportion of severe cases receiving in-patient care, 
μ, because of the higher mortality (CFR: Qc) of severe 
malaria cases who are not admitted [14], so that:
Both in-patient and community malaria mortality 
were re-estimated based on each of the estimates of the 
country-specific proportions of severe cases receiving in-
patient care (µPB and µDA).
Neither WMR estimate, Dˆt, nor the OpenMalaria esti-
mate, Dt,µ0, of overall mortality rates, allow for variation 
in µ, but improved country specific estimates of overall 
malaria mortality can be obtained using µPB or µDA for 
the proportion of severe cases receiving in-patient care in 
each case using the estimates of case fatality rates from 
OpenMalaria:
where DˆDA and DˆPB are scaled with the factor ρ to the 
average mortality in WMR.
Potential public health impact of improving access 
to in‑patient care
The potential reduction in mortality, R, that would be 
achieved by increasing access to in-patient care for all 
severe malaria cases, is obtained by taking the difference 
between estimated mortality, Dˆ, with current estimated 
levels of access to in-patient care (µPB or µDA) and the 
mortality obtained by assuming 100% access to in-patient 
care (µ = 1), namely:
(12)SDA =
Dˆc
Qc
+
Dˆh
Qh
=
Dˆc
Qc
+ rˆhCˆh,
(13)µDA =
Sˆh
SDA
=
Dˆh(
Qh/Qc
)
Dˆc + Dˆh
=
rˆhCˆh
rˆhCˆh + Dˆc/Q¯c
(14)Dt = µQhSt + (1− µ)QcSt .
(15)DˆPB = ρSt
(
µPBQh + (1− µPB)Qc
)
,
(16)DˆDA = ρSt
(
µDAQh + (1− µDA)Qc
)
,
(17)RˆPB = ρSt(1− µPB)
(
Qc − Qh
)
,
Sensitivity analyses
We undertook a sensitivity analysis to examine how esti-
mates of severe disease and mortality depend on assump-
tions about the odds ratio of dying in the community 
compared to in-patient (ϕ1) and the related parameter of 
proportion of severe cases receiving in-patient care (µ). 
The analysis is described in the Additional file 1.
Results
The burden and access statistics described in the results 
were computed for each of the 41 malaria endemic coun-
tries. Malaria burden estimates from the World Malaria 
Report and the OpenMalaria simulations are given in the 
Supporting Information Table 2. These are derived from 
the national level distributions of EIR for 2014 detailed in 
the Additional file 1: Figure S1 and Table S1.
The derived country specific values for access to care 
and case fatality rates are given in Table  2 and Fig.  1. 
The in-patient CFRs from WMR, Qˆh, vary consider-
ably, ranging from 0 (Eritrea and Mauritania) to 15% 
(Sierra Leone). In contrast, the OpenMalaria in-patient 
case fatality rates, Qc, are very similar across countries, 
reflecting the fact that they depend only on differences in 
the modelled age-distributions of severe malaria cases. 
The OpenMalaria CFRs are higher than those from 
WMR, with the exceptions of three countries, Liberia, 
Botswana and Sierra Leone, for which the ratio of severe 
to clinical cases is greater than 1 (rh > 1). For these three 
countries we assumed for subsequent calculations that all 
in-patients have severe disease, (rh = 1). The estimates of 
the proportions of in-patients that are severe, rh, range 
from 10 to 70% for most of the countries (Table 2).
Low in-patient case fatality rates (Qˆh) are to be 
expected in those countries where uncomplicated cases 
are frequently admitted to in-patient facilities. Admission 
of uncomplicated cases was not considered in the simula-
tion models so it does not affect the OpenMalaria CFR, 
Qh. However, in WMR, very high rates of in-patient mor-
tality (Qˆh) can derive from poor quality of case-manage-
ment, or arise because patients have difficulty accessing 
care until it is too late (both reflecting poor health sys-
tem performance). High in-patient CFR, Qˆh, values might 
also arise because of strict referral or admission crite-
ria, indicated by a high ratio of severe to uncomplicated 
cases among the admissions, rh. If rh could be estimated 
independently, then a high value of rh associated with a 
low value of Qˆh would indicate an efficient system of ter-
tiary care for severe malaria, but unfortunately we have 
no estimate of rh that is independent of the CFRs. The 
ratio of severe to uncomplicated cases, rh, is not corre-
lated with the quality of care for uncomplicated malaria, 
(18)RˆDA = ρSt(1− µDA)
(
Qc − Qh
)
.
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Table 2 Country specific access to care, case fatality rates, and in-patient malaria incidence
a Ranges represent the estimates using the lower and upper bound of deaths estimates in WMR
b Uˆh estimated as: Uˆh = Cˆh − Sˆh; Sˆh estimated as Sˆh =
Dˆh
Qh
Access to care Cases fatality rate (CFR) In‑patient cases 
(per 100,000 person 
per year)
Effective access 
to care for uncom‑
plicated cases
Proportion admit‑
ted as in‑patients
Community In‑patient In‑patient fatality 
rate ratio
Uncomplicated Severe
OM WMR OM WMR/OM
Country Code E14 µPB µDAa Qc Qˆh Qh rˆh Uˆhb Sˆhb
Angola ago 0.49 0.74 0.57 (0.43;0.78) 0.15 0.02 0.08 0.3 689.7 296.1
Benin ben 0.3 0.43 0.45 (0.36;0.59) 0.15 0.02 0.08 0.26 628.9 225.4
Botswana Bwa 0.71 0.11 1 (–;–) 0.16 0.14 0.08 1.74 0 11.9
Burkina Faso bfa 0.34 0.78 0.49 (0.29;0.63) 0.14 0.01 0.07 0.16 2209.5 427.2
Burundi bdi 0.38 0.86 0.96 (0.68;1) 0.16 0.02 0.08 0.24 1081.3 337.5
Cameroon cmr 0.26 0.53 0.63 (0.47;0.91) 0.15 0.01 0.08 0.12 1829 240.1
Chad tcd 0.1 0.65 0.35 (0.26;0.68) 0.17 0.04 0.09 0.42 204.9 146.2
Central Afr Rep. caf 0.17 0.34 0.28 (0.22;0.37) 0.15 0.02 0.08 0.26 483.6 167.9
Comoros com 0.27 0 0 (0;0) 0.15 0 0.08 0 136.2 0
Congo cog 0.38 0.16 0.28 (0.2;0.95) 0.15 0.01 0.08 0.13 490.1 74.9
Rép. Dém. du Congo cod 0.26 0.86 0.67 (0.51;0.87) 0.15 0.03 0.08 0.33 888.4 435.1
Côte d’Ivoire civ 0.25 0.2 0.22 (0.18;0.29) 0.15 0.03 0.08 0.4 184 124.1
Djibouti dji 0.47 1 0.71 (–;–) 0.16 0.02 0.09 0.28 96.2 37.4
Eritrea eri 0.08 0.1 0.2 (0.1;1) 0.18 0 0.09 0.04 72.1 3.2
Ethiopia eth 0.14 0.21 0.06 (0.02;0.94) 0.18 0.01 0.1 0.07 31.5 2.3
Gabon gab 0.4 0.26 0.59 (0.47;1) 0.15 0.01 0.08 0.07 1539 121.1
The Gambia gmb 0.37 0.53 0.43 (0.3;1) 0.17 0.03 0.09 0.34 193.1 97.8
Ghana gha 0.31 0.2 0.26 (0.21;0.53) 0.15 0.01 0.08 0.07 1498.4 106.7
Guinea gin 0.21 0.21 0.18 (0.15;0.25) 0.15 0.01 0.08 0.13 800.3 115.6
Guinea Bissau gnb 0.29 0.74 0.68 (0.52;1) 0.16 0.03 0.09 0.32 498.6 231.5
Kenya ken 0.35 0.04 0.09 (0.07;0.31) 0.15 0.02 0.08 0.28 33.7 13.1
Liberia lbr 0.42 1 1 (0.88;1) 0.14 0.08 0.07 1.08 0 696.9
Madagascar mdg 0.22 0.12 0.28 (0.13;1) 0.17 0.06 0.09 0.68 12.5 26.4
Malawi mwi 0.4 0.71 0.72 (0.57;1) 0.15 0.05 0.08 0.64 189.4 339.2
Mali mli 0.2 0.31 0.2 (0.16;0.26) 0.15 0.04 0.08 0.48 198.3 179.7
Mauritania mrt 0.22 0.04 0.03 (0.02;0.14) 0.17 0 0.09 0.02 326.2 5.4
Mozambique moz 0.38 0.3 0.32 (0.26;0.5) 0.15 0.03 0.08 0.45 188.6 156.3
Namibia nam 0.44 0.13 1 (–;–) 0.16 0.04 0.08 0.5 30.5 30.9
Niger ner 0.39 0.38 0.36 (0.27;0.53) 0.15 0.01 0.08 0.18 831 180.6
Nigeria nga 0.32 0.08 0.09 (0.08;0.14) 0.15 0.01 0.08 0.09 478.7 44.8
Rwanda rwa 0.54 0.19 0.28 (0.19;1) 0.16 0.04 0.08 0.54 45.3 52.9
São Tomé e Prìncipe stp 0.54 0 0 (–;–) 0.15 0 0.08 0 223.8 0
Senegal sen 0.32 0.15 0.2 (0.14;0.86) 0.17 0.04 0.09 0.45 47.6 38.5
Sierra Leone sle 0.5 1 0.53 (0.4;0.66) 0.14 0.15 0.07 2.1 0 618
Somalia som 0.08 0.02 0.01 (0.01;0.49) 0.17 0.01 0.09 0.12 10.7 1.5
Sudan sdn 0.25 0.2 0.39 (0.22;1) 0.17 0.01 0.09 0.07 320.4 23
Tanzania tza 0.46 0.33 0.48 (0.37;1) 0.16 0.03 0.08 0.31 284.4 126.4
Togo tgo 0.32 0.41 0.4 (0.33;0.55) 0.15 0.04 0.08 0.48 246.7 224.7
Uganda uga 0.66 0.59 0.63 (0.51;1) 0.15 0.01 0.08 0.13 1438.3 207.3
Zambia zmb 0.59 0.66 0.65 (0.51;1) 0.15 0.02 0.08 0.28 701.6 271.7
Zimbabwe zwe 0.32 0.16 0.26 (0.13;1) 0.17 0.05 0.09 0.6 20.4 30.1
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as measured by E14 (Pearson correlation coefficient 0.39 
[0.098–0.63], Additional file 1: Figure S4).
Data gaps in WMR [5] affect estimates of the pro-
portion of severe disease cases admitted for several 
countries. In particular, for South Sudan and Equato-
rial Guinea, WMR does not contain data on in-patient 
mortality and thus the proportion of severe cases 
admitted could not be estimated for those two coun-
tries. For Botswana, Djibouti and Namibia, all countries 
with low malaria incidence, WMR gives estimates of 
total deaths as an upper bound, lower than the num-
ber of in-patient deaths reported, so for these coun-
tries the in-patient report provides the best estimate of 
total mortality and the proportion of severe cases that 
are admitted is assumed to be 100%. Similarly, in both 
Comoros and São Tomé and Príncipe the in-patient 
deaths are reported to be 0 which leads to estimates of 
μDA = μPB = 0.
In general, the OpenMalaria simulations predicted 
much higher mortality rates than those in WMR, with 
the overall ratio calculated to be ρ = 0.45. Estimates of 
the proportion admitted (both of µPB and µDA computed 
by reweighting using ρ), for countries with complete data 
cover the whole range from little more than 0–100% 
(Fig. 1). For many countries µDA is extremely uncertain, 
as illustrated by the uncertainty bounds, which corre-
spond to the upper and lower bounds for the estimated 
mortality rates from WMR. Corresponding bounds are 
not available for µPB but this does not mean that either 
of these estimates is more accurate than the other. Esti-
mates of µDA and µPB are strongly correlated with each 
other (Fig.  2), but by no means identical. Neither esti-
mate of access to care for severe disease is strongly cor-
related with effective access to care for uncomplicated 
malaria (E14; Additional file  1: Figure S2) and nor is 
there any clear relationship of either measure with DTP3 
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care, µ, by method of estimation. Colour indicates method with the prediction biased estimate (µPB) in orange and the deaths-adjusted estimate 
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vaccination coverage (a frequently used measure of 
health system performance; Additional file 1: Figure S3). 
Correlation to other measures such as the transmission 
with the mean EIR (Pearson coeff. −0.031 [−0.033–0.28] 
and 0.26 [−0.046–0.53] for deaths-adjusted and predic-
tion-biased estimates respectively), the IQR of the EIR 
distribution (Pearson coeff. −0.080 [−0.23–0.38] and 
0.40 [−0.11–0.64] for deaths-adjusted and prediction-
biased estimates respectively), or the correlation to the 
national GDP (Pearson coeff. 0.36 [0.025–0.61] and 
−0.20 [−0.50–0.14] for deaths-adjusted and prediction-
biased estimates respectively) have been assessed, but no 
correlation has been found.
Corresponding to the estimates of µPB and µDA are 
values of the incidence of severe disease, SDA and SPB 
(Fig. 3a) which vary over a large range, showing a plausi-
ble increase with malaria endemicity (Fig. 3a). Estimated 
SDA and SPB are strongly correlated, but not identical, 
with the deaths-adjusted estimates SDA substantially 
higher in some high endemicity countries, in particular 
Sierra Leone, Burkina Faso and Mali.
The estimates of malaria mortality rates also vary 
enormously between countries (Fig.  3b). The scaling of 
the two estimates, DˆPB and DˆDA, ensures that on aver-
age, they are close to WMR values, and the two adjusted 
estimates are generally similar, both suggesting lower 
mortality than WMR in countries with high access to 
in-patient care, and higher mortality where access to in-
patient care is poor (Fig. 4).
A theoretical admission rate for severe malaria of 100% 
would decrease malaria burden, and the deaths averted in 
each country if it would reach this ideal level is shown in 
Fig. 5a. The general pattern of the estimates of potential 
public health impact of improving access to in-patient 
care is similar to that of the estimates of the mortal-
ity rates. The two predictions of the potential number 
of deaths averted by improving access to in-patient care 
are strongly correlated (concordance correlation of 0.88 
[0.78–0.93]) and both indicate that the potential gains 
in survival are considerable (Fig. 5a). When expressed as 
estimates of the proportion of malaria deaths that may 
be averted (Fig.  5b) a large number of countries cluster 
in the top right of the plot. These are countries with low 
estimates of access to in-patient care, for which both 
RˆPB/DˆPB and RˆDA/DˆDA approach an upper limit corre-
sponding to Qh/Qc.
The sensitivity analysis (Additional file  1) of the 
dependence of Qc, µ, Sc and Dt on ϕ1, indicated that 
many of these estimates are strongly related to the highly 
uncertain odds ratio of dying in the community com-
pared to in-patient, ϕ1, when the relatively well-defined 
parameters are fixed. This is especially the case for 
Qc which is close to linearly related to ϕ1. If ϕ1 is much 
greater than the OpenMalaria value of 2.1 (and Qc there-
fore also higher than the core estimates, as in Thwing 
et al. [4]) then the primary estimates substantially under-
state the variation between countries in the incidence of 
severe malaria cases that are not admitted.
Discussion
National level statistics on numbers of malaria in-patient 
admissions are part of routine reporting [5], but the cri-
teria for admission of a malaria case vary considerably 
between countries (and probably also within countries). 
The analysis in this work shows that, on one hand, in 
most African countries far more patients are admitted 
than would meet strict criteria for severe (life-threaten-
ing) malaria. But, on the other hand it is likely for many 
countries that only a small proportion of severe cases are 
admitted for in-patient treatment.
Given far more patients are estimated to be admit-
ted for in-patient care than are strictly severe malaria 
(defined by WHO as malaria with signs of severe illness 
and/or evidence of vital organ dysfunction, [24]) suggests 
possible inefficient use of in-patient resources and points 
to a need to investigate potential improvements in refer-
ral and admission practices, in many, but not all coun-
tries. This should be considered in estimating both the 
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estimates. The black line indicates µPB = µDA line, and each country is 
indicated via their country code (Table 2)
Page 9 of 12Camponovo et al. Malar J  (2017) 16:1 
public health impact of in-patient care, and also the costs 
associated with malaria treatment in general.
Not only are severe malaria cases a small proportion of 
admissions, but this work also suggests that a potentially 
worryingly small proportion of severe cases are admit-
ted in many African countries. There is considerable het-
erogeneity in access to effective care for uncomplicated 
malaria across the continent [9], but the national level 
admission rates for severe malaria estimated in this work 
vary even more, covering the whole range between 0 and 
100%. The weak correlation at country level between 
access for severe and uncomplicated disease (Addi-
tional file  1: Figure S2) is perhaps surprising (because 
both depend on the quality of both the health-care and 
transport systems), but trade-offs in resource alloca-
tion between out-patient and in-patient care might play 
a role. Alternatively, the low reported admission rates in 
some countries, for instance Nigeria, could reflect incom-
plete reporting rather than poor access. Low reported 
admission rates arise when data from the private sector 
are omitted. As another example, in Liberia, the total 
deaths reported by WMR are close to the deaths reported 
among in-patients (2288 against 2200). This could only 
be correct in the unlikely scenario that almost all severe 
cases in the country are admitted. At both end of the 
spectrum there may well be substantial reporting biases.
There are a number of limitations to these international 
comparisons of severe malaria incidence and mortality, 
the key shortcoming being the dependence on data that 
is, at best, poorly defined, and, at worst, highly flawed. 
This contrasts with data on prevalence and (to a lesser 
extent) clinical malaria incidence, which are increas-
ingly collected using standardized survey (DHS and MIS) 
methodologies. These analyses also depend on indirect 
inferences and simplifying assumptions made in the mod-
els. This includes not accounting for differences between 
countries in the average quality of care, in the efficiency 
of referral, and hence in timeliness of admission, as well 
as the assumption of uniformity in the outcome once a 
severe case is admitted. General understanding of the 
fatality rates may be substantially improved through good 
data on not only how many are dying or getting treated, 
but also whom.
The most uncertain inputs into the model relate to the 
proportions of severe malaria cases that are admitted, 
and concomitantly, to the scale of mortality due to unre-
corded severe malaria in the community. The use of coun-
try specific admission rates from WMR does not help 
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Fig. 5 Expected national mortality reduction if access to severe in-patient treatment was universal. a prediction of the potential reduction in mor-
tality rate (per year per 100,000) and (b) predictions of the potential reduction in mortality as a proportion of current predicted burden achieved by 
improving access to in-patient care. In both panels, the horizontal axis indicates predictions assuming the deaths-adjusted estimation method and 
the vertical axis indicates predictions assuming the prediction-biased estimation method. Each country is indicated via their country code (Table 2) 
and the black line represents the line of equality between the two estimates. In a the concordance correlation co-efficient was estimated as 0.87 
with confidence interval of [0.77–0.93] indicating close agreement between the two mortality estimates. In b the concordance correlation co-
efficient was estimated as 0.57 with confidence interval of [0.32–0.75] indicating moderate agreement between the two estimates
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much in identifying these quantities, and further stud-
ies are needed with alternative data sources such as high 
resolution spatial data, length of history from in-patients, 
and records of treatment histories collected during ver-
bal autopsies [25]. Such studies need to take into account 
the clear evidence that both disease incidence and access 
to in-patient care is hugely variable in space and time. 
OpenMalaria was parameterized mainly using data from 
the late twentieth century [14] and predicts higher mor-
tality rates at a given level of malaria transmission than 
those in WMR, which are informed by more data from 
recent, lower general mortality settings. In this context, 
rescaling OpenMalaria severe disease incidence so that 
the continent-wide mortality rates matches that from 
WMR is coherent with overall decreases in infectious 
disease rates together with a contribution of co-infection 
to pathogenesis of severe malaria (as modelled in Open-
Malaria [14]).
The weakness of data sources on severe disease is par-
ticularly troubling considering that averting mortality is 
the main reason for intervening against malaria. Since 
malaria is a treatable disease and treatment impacts 
onward transmission [22], levels of access to curative care 
are an important determinant of both disease burden and 
the public health impact of both preventive and cura-
tive interventions. If no-one is dying of malaria anyway, 
for whatever reason, then preventive interventions obvi-
ously cannot avert any deaths. Current mortality rates, 
the numbers of deaths that are already being prevented, 
and the numbers that could be prevented in the future by 
vector control, vaccination, or treatment, all depend on 
levels of access both to prompt and effective treatment of 
fevers, and to effective in-patient care for severe disease. 
Few analyses of either burden or the impact of preventive 
interventions against P. falciparum in Africa consider this 
[26, 27].
There is a clear need for effective coverage of both out-
patient and in-patient care to be appropriately taken into 
account both in burden estimation and in analyses of the 
potential public health impact of improvements in both 
curative and preventive programmes. WMR uses lev-
els of access to care for fevers to correct for incomplete 
reporting, but the national-level estimates of burden, 
do not allow for the effective coverage of treatment for 
either uncomplicated or severe disease. For high bur-
den countries, the Child Health Epidemiology Reference 
Group’s verbal autopsy data-based multicause models 
[28, 29] (used to estimate Dˆt in this work), considers cov-
erage of LLINs, but not of treatment. Adult mortality is 
inferred from child-mortality rates and endemicity, using 
the relationship estimated in Ross et al. [14]. For lower-
burden countries, WMR multiplies the overall estimated 
case incidence by standard CFR estimates to obtain Dˆt 
but the proportion of cases treated does not adjust Dˆt 
downwards. In addition, not explicitly accounting for 
the fate of severe malaria cases that do not make it to 
health facilities implies that national level burden of dis-
ease statistics for P. falciparum malaria, such as WMR, 
are also highly uncertain. Recently, several geography-
specific predictions of malaria intervention impact and 
cost-effectiveness from OpenMalaria have allowed for 
national levels of effective treatment for uncomplicated 
disease [30, 31], but so far not for variations in access to 
in-patient care. It is not clear whether even these analy-
ses accurately capture the quantitative impact of access 
to effective of treatment on subsequent burden, since the 
strength of this relationship is not well calibrated against 
field data, which is also lacking.
Conclusion
There is a pressing need for more convincing data on 
both admission rates for severe malaria and the total 
numbers of severe malaria cases in different endemic 
countries in Africa. The available evidence suggests that 
access to in-patient care for severe malaria varies consid-
erably between countries, and the potential impacts of 
improvements in access to and quality of in-patient care 
are also strongly country-dependent. The model-based 
analyses proposed here offer a practicable start to incor-
porating severe disease rates into a common framework 
for comparing public health impact of preventive and 
curative interventions. It will allow both international 
and national level resource allocation decisions to make 
valid comparisons of the mortality impacts of different 
kinds of intervention packages.
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